CENTER FOR FOOD AND DRUGINSPECTION OF NMPA NATIONAL CENTER FOR VACCINE INSPECTION

中文

China's vaccine regulatory system passes WHO assessment
2022-08-24
NMPA Issues Announcement on the Second list of people qualified as National Cosmetics InspectorsYJZZ [2021] No.59
2021-07-05
Pharmaceutical Professional Inspector General Team of Hebei province organized and carried out quality management system training
2020-12-10
The Training Course for Cosmetic Inspectors Was Successfully co-held by CFDI and National Medical Product Administration Institute of Executive Development
2020-12-02
The Cosmetics Inspection Work Experience Exchange Meeting was successfully Held in CFDI
2020-12-02
The CFDI Successfully Held the Second Phase of the National Cosmetics Inspector Skills Training
2020-08-24
The On-site Inspection Skills Training for Special Food Inspectors Was Successfully Held in CFDI
2019-05-06
The Announcement of China Drug Administration on Suspending the Sales and Use of Quetiapine Fumarate made by Dr. Reddy’s Laboratories Ltd. in India (No.61, 2018)
2018-09-11
CFDI Organized the First Batch of Unannounced Inspection of Food Production Enterprises in 2018
2018-06-20
The Announcement of China Drug Administration on Suspending the Sales and Use of Imipenem and Cilastatin Sodium for Injection made by Sun Pharmaceutical Industries Ltd in India (No.21, 2018)
2018-05-15
Announcement of China Food and Drug Administration on Suspending the Import of HER-2 Assay Kit (IHC) of Leica Biosystems Newcastle Ltd (No.153, 2017)
2017-12-15
Announcement of China Food and Drug Administration on Suspending the Import of Calcium Sulfate and Absorbable Artificial Bone Powder Products of Biocomposites.Ltd (No.152, 2017)
2017-12-15
CFDA issues the Announcement of withdrawal registration applications for 135 drugs from 106 Companies (No.80, 2017)
2017-07-04
Notice (No. 77 [2017]) of CFDA on Issuing the Four Guidelines including Guideline on the R&D On-site Inspection for Quality and Efficacy Consistency Evaluation of Generic Drugs
2017-05-19
CFDA issues the Announcement of Banning the Importation of Bacterial Lysates Capsules from OM Pharma SA in Switzerland (No. 30, 2017)
2017-03-21
Announcement of Overseas On-site Inspection for Imported Drugs (I) in 2017
2017-03-08
Notice (No. 11 [2017]) of CFDA on Issuing the Guideline for General Considerations for Drug Clinical Trials
2017-01-20
CFDA issues the Announcement of the Registration Application of Self-examination and Inspection of Drug Clinical Trial Data (No. 202, 2016)
2017-01-05
CFDA issues the Announcement of Registration Application of Self-examination and Inspection of Drug Clinical Trial Data (No. 171, 2016)
2016-11-05
CFDA issues the Announcement of Self-Examination and Inspection Situations for the Drug Clinical Trial Data of the Registration Applications (No.142, 2016)
2016-09-01

<
<<
1
2
3
>>
>
show pageOK

Home Hot Topics What’s new Normative Documents & Guidance Laws & Regulations About CFDI